Ileorectostomy is an operation we perform often for patients with colonic Crohn’s disease but in whom the rectum must be normal, or very minimally involved, and you can tell that by inflating air into the rectum and seeing if it blows up normally. If it doesn’t, then the surgeon would be anastomosing the small bowel to a rigid pipe of rectum, which is totally unacceptable for long term control of continence. There can be really no anal pathology either, and they can’t already have short bowel.
Here is our general experience with ileorectostomy for Crohn’s disease, in 80 patients and with a reasonable mortality, but in our thought process we figure a third, a third, a third. A third of the patients will go from a ileorectostomy to Brooke ileostomy at some point in their postoperative course. Another third will have their ileorectostomy in place but doing poorly; poor control, lots of stools and so forth. But only a third have a fully satisfactory, long term outcome with ileorectostomy for Crohn’s disease.
What about this change in intrarectal Crohn’s? Well in Crohn’s disease of the anus it is surprising how often this is misdiagnosed when patients come to us. It’s really pretty simple. If the patients have huge skin tags, fissures, big ulcers in the anal canal -often not uncomfortable – there is a blue discoloration, cyanotic hue to the perianal area. That they are stricturing, that as you do a digital you can barely get your finger in, it’s a circumferential stricture at the top of the anal canal, or they have fistulas in funny locations. I mean, it’s obvious that this patient … and they have the symptoms of internal inflammatory bowel disease, it’s obvious that they have Crohn’s disease of the anus. But it is not so obvious if the patients are completely symptom free, no obvious evidence of proximal involvement, but they do indeed have anal Crohn’s.
What are we doing today? Well, thanks to – at least at our institution – our gastroenterologists are aggressively treating patients with anal Crohn’s disease, and the role of the surgeon has changed a little bit. We are still draining abscesses, placing setons as drains through complex fistulas to keep them drained so that they don’t form abscesses, and we medicate – in this era of anti-TNF alpha – we medicate these people aggressively. We will take them back to the operating room as necessary and the goal is to dry up the perianum. I think if you watch the literature for the next several months and years, that I think this is a rational approach in patients – particularly in younger patients – before we even think about having to excise the perianum and the anus for perianal Crohn’s disease.
Recent Comments